(Q43551289)

24 November 2017

title

Decreased effect of immunosuppression on immunocompetence in African--Americans after kidney and liver transplantation (English)

1 reference

24 November 2017

1 reference

liver transplantation

1 reference

Nagashima N

1

1 reference

24 November 2017

Watanabe T

2

1 reference

24 November 2017

Nakamura M

3

1 reference

24 November 2017

Shalabi A

4

1 reference

24 November 2017

Burdick JF

5

1 reference

24 November 2017

publication date

1 April 2001

1 reference

24 November 2017

published in

Clinical Transplantation

1 reference

24 November 2017

volume

15

1 reference

24 November 2017

issue

2

1 reference

24 November 2017

page(s)

111-115

1 reference

Immunosuppressive therapy in high-risk transplant patients: dose-dependent efficacy of mycophenolate mofetil in African-American renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150207.X

Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150207.X

Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150207.X

FK506 markedly enhances apoptosis of antigen-stimulated peripheral T cells by down-regulation of Bcl-xL

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150207.X

Peripheral blood antigen-presenting cells from African-Americans exhibit increased CD80 and CD86 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150207.X

A promoter polymorphism of tumor necrosis factor alpha associated with systemic lupus erythematosus in African-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150207.X

Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150207.X

7 January 2021

Novel concept for easy quantification of posttransplant immunocompetence

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150207.X

7 January 2021

Cell-mediated lympholysis studies in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150207.X

7 January 2021

Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150207.X

7 January 2021

The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150207.X

7 January 2021

Cytokine gene polymorphisms predict acute graft rejection following renal transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150207.X

7 January 2021

Transforming growth factor-beta 1 hyperexpression in African American end-stage renal disease patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150207.X

7 January 2021

10.1034/J.1399-0012.2001.150207.X

Identifiers

DOI

1 reference

24 November 2017

1 reference